ANI Pharmaceuticals Inc (ANIP)

48.09
0.45 0.93
NASDAQ : Health Care
Prev Close 48.54
Open 48.30
Day Low/High 47.71 / 48.66
52 Wk Low/High 26.80 / 73.54
Volume 18.17K
Avg Volume 126.50K
Exchange NASDAQ
Shares Outstanding 11.65M
Market Cap 563.66M
EPS 0.30
P/E Ratio 151.22
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Bearish Bets: A Drug Maker, a Boutique Retailer and Other Stocks That Look Good Short

MBI, CMP, FRAN, ANIP and PHX all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABDC, BCBP, CERN, DVA, EDGW, GRUB, INS, LRN, MET, NC, NEWS, OAK Downgrades: ANIP, BBSI, CVG, FRAN, FTD, MHLD, PHX Initiations: NVTR, SNDX Read on to get TheStreet Quant Ratings' detailed report:

Commit To Purchase ANI Pharmaceuticals At $35, Earn 7.9% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals Inc shares, but cautious about paying the going market price of $49.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $35 strike, which has a bid at the time of this writing of $1.70.

ANI Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ANIP

In trading on Wednesday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $59.71, changing hands as low as $59.61 per share. ANI Pharmaceuticals Inc shares are currently trading off about 5.4% on the day.

Notable Two Hundred Day Moving Average Cross - ANIP

Notable Two Hundred Day Moving Average Cross - ANIP

In trading on Thursday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $57.58, changing hands as low as $57.03 per share. ANI Pharmaceuticals Inc shares are currently trading down about 2% on the day.

5 Stocks Poised for Major Breakouts

5 Stocks Poised for Major Breakouts

These stocks are within range of triggering breakout trades. Here's how to trade them from here.

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

In trading on Thursday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $51.16, changing hands as low as $47.25 per share. ANI Pharmaceuticals Inc shares are currently trading off about 23.4% on the day.

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

The Baudette, Minn.-based company has 79 products generating about $4 billion in sales and a number of other promising therapies in its pipeline.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANIP, AXU, BLDP, DVD, EGN, GPIC, IEC, IRS, OVBC, PIH, SAIA, VCO, WILC Downgrades: EFOI, LILAK, PCH, PEGA, PNM, PW, SUI, TOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

ANIP Crosses Above Average Analyst Target

ANIP Crosses Above Average Analyst Target

In recent trading, shares of ANI Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $66.00, changing hands for $66.39/share.

Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)

Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a strong on high relative volume candidate

Commit To Purchase ANI Pharmaceuticals At $45, Earn 9.7% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $45, Earn 9.7% Annualized Using Options

Investors eyeing a purchase of ANI Pharmaceuticals, Inc. stock, but cautious about paying the going market price of $59.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.

These 5 Stocks Are Ready to Break Out

These 5 Stocks Are Ready to Break Out

Here's a technical look at how to trade five stocks poised for breakouts.

Commit To Purchase ANI Pharmaceuticals At $35, Earn 12.4% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $35, Earn 12.4% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $47.54/share, might benefit from considering selling puts among the alternative strategies at their disposal.

2 Small Biopharma Stocks on the Move

The oversold biotech sector is recovering.

Cashing In on the Biotech Bear Market

My 4-Tier approach to deploying new capital in the sector.

ANI Pharmaceuticals Enters Oversold Territory (ANIP)

ANI Pharmaceuticals Enters Oversold Territory (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase ANI Pharmaceuticals At $22.50, Earn 13% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $22.50, Earn 13% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $35.88/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Perilous Reversal Watch: ANI Pharmaceuticals (ANIP)

Perilous Reversal Watch: ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Dead Cat Bounce Stock Is ANI Pharmaceuticals (ANIP)

Today's Dead Cat Bounce Stock Is ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate

ANI Pharmaceuticals (ANIP) Marked As A Dead Cat Bounce Stock

ANI Pharmaceuticals (ANIP) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate